The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) held its seventh meeting from 4 to 7 February 2013.
For an overview of all information available following the meeting of the PRAC, please see the table below.
The Agency publishes a new page following the PRAC meeting each month. The minutes of each PRAC meeting will be published during the week following the subsequent PRAC.
|Agenda – PRAC draft agenda of meeting 4-7 February 2013|
Start of referral procedures
|Combined hormonal contraceptives|
|Cyproterone/ethinylestradiol (2mg/0.035mg) containing medicinal products|